Identification of novel HIV-1-derived HLA-E-binding peptides-Reference-Cited by-同舟云学术

Identification of novel HIV-1-derived HLA-E-binding peptides

Published:2018-10 Issue: Volume:202 Page:65-72
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Hannoun Zara^ORCID,Lin Zhansong,Brackenridge Simon,Kuse Nozomi,Akahoshi Tomohiro,Borthwick Nicola,McMichael Andrew^ORCID,Murakoshi Hayato,Takiguchi Masafumi,Hanke Tomáš^ORCID

Funder

Medical Research Council (MRC) UK

UK Department for International Development

Ministry of Education, Science, Sports, and Culture, Japan

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference63 articles.

1. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence;Petrie;J. Exp. Med.,2008

2. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C;Braud;Nature,1998

3. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A;Lee;Proc. Natl. Acad. Sci. U. S. A.,1998

4. Characteristics of HLA-E restricted T-cell responses and their role in infectious diseases;Joosten;J. Immunol. Res.,2016

5. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes;Arlettaz;Eur. J. Immunol.,2004

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Multiple Roles of Gamma Interferon in Intraepithelial T Cell-Villous Enterocyte Interactions in Active Celiac Disease;2024-09-06

2. Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies;Frontiers in Immunology;2024-09-05

3. NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity;Biomedicines;2024-07-25

4. An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis;Proceedings of the National Academy of Sciences;2024-05

5. Instability of the HLA-E peptidome of HIV presents a major barrier to therapeutic targeting;Molecular Therapy;2024-03